Equity and Outcome Events in Hidradenitis Suppurativa: Exploring Effect Modifiers Associated with Diagnostic Delay in the Real World
Abstract Introduction Patients with hidradenitis suppurativa (HS) experience significantly delayed diagnoses of 7-10 years from symptom onset on average, but the reasons for this remain largely unknown. This study investigated drivers of diagnostic delay from the perspective of healthcare system equ...
Saved in:
Main Authors: | Nicole Murray (Author), Isabel Truman (Author), Gary Milligan (Author), Himanshu Modi (Author), Nicholas Adlard (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Female sex and younger age are associated with hidradenitis suppurativa diagnostic delay
by: Fatuma-Ayaan B. Rinderknecht, MS, et al.
Published: (2023) -
Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real‐world experience from Spain
by: Eva Vilarrasa, et al.
Published: (2024) -
Phenotype Algorithms to Identify Hidradenitis Suppurativa Using Real-World Data: Development and Validation Study
by: Jill Hardin, et al.
Published: (2022) -
Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab
by: Ryan C. Saal, BS, et al.
Published: (2023) -
Real-Life Experience of Secukinumab in Patients With Hidradenitis Suppurativa
by: F.J. Melgosa Ramos, et al.
Published: (2023)